ES8101585A1 - Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico - Google Patents

Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico

Info

Publication number
ES8101585A1
ES8101585A1 ES488665A ES488665A ES8101585A1 ES 8101585 A1 ES8101585 A1 ES 8101585A1 ES 488665 A ES488665 A ES 488665A ES 488665 A ES488665 A ES 488665A ES 8101585 A1 ES8101585 A1 ES 8101585A1
Authority
ES
Spain
Prior art keywords
hyperlipoproteinaemia
isobutyrate
para
hypolipaemic
hypocholesterolaemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES488665A
Other languages
English (en)
Other versions
ES488665A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sociedad Espanola de Especialidades Farmaco Terapeuticas SA
Original Assignee
Sociedad Espanola de Especialidades Farmaco Terapeuticas SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sociedad Espanola de Especialidades Farmaco Terapeuticas SA filed Critical Sociedad Espanola de Especialidades Farmaco Terapeuticas SA
Priority to ES488665A priority Critical patent/ES488665A0/es
Priority to FR8017235A priority patent/FR2476095A1/fr
Priority to BE2/58700A priority patent/BE884722A/fr
Publication of ES8101585A1 publication Critical patent/ES8101585A1/es
Publication of ES488665A0 publication Critical patent/ES488665A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE 2-P-CLOROFENOXIISOBUTIRATO-1,3-DINICOTINATO DE TRIHIDROXIPROPANO. CONSISTE EN HACER REACCIONAR EN REACCION DE ESTERIFICACION, DEL ACIDO P-CLOROFENOXIISOBUTIRICO CON EL 1,3-DIHALOGENO-2-PROPANOL, EN UN MEDIO DISOLVENTE INERTE (TAL COMO BENZOL, TOLUOL O XILOL). EN LA REACCION SE EMPLEAN CATALIZADORES Y MEDIOS DE CAPTACION DEL AGUA PRODUCIDA EN LA REACCION. SE OBTIENE EL COMPUESTO 2,P-CLORO-FENOXIISOBUTIRATO DE 1''.3''-DIHALOGENO-ISOPROPILO, QUE SE HACE REACCIOANR CON LA SAL NICOTINICA DE UN METAL ALCALINO. SE OBTIENE UN COMPUESTO DE FORMULA ESTRUCTURAL (I). *FORMULA* TRATAMIENTO DE HIPERLIPEMIAS E HIPERCOLESTEROLEMIAS PRIMARIA O SECUNDARIA. PREVENCION DE ARTERIOSCLEROSIS.
ES488665A 1980-02-15 1980-02-15 Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico Granted ES488665A0 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES488665A ES488665A0 (es) 1980-02-15 1980-02-15 Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico
FR8017235A FR2476095A1 (en) 1980-02-15 1980-08-01 Glyceryl 2-para-chloro:phenoxy-isobutyrate-1,3-di:nicotinate - hypolipaemic and hypocholesterolaemic used to treat atherosclerosis, hyperlipoproteinaemia and high tri:glyceride plasma levels
BE2/58700A BE884722A (fr) 1980-02-15 1980-08-12 Nouvel ester mixte symetrique de 1,2,3-trihydroxypropane, son procede d'obtention et ses applications therapeutiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES488665A ES488665A0 (es) 1980-02-15 1980-02-15 Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico

Publications (2)

Publication Number Publication Date
ES8101585A1 true ES8101585A1 (es) 1980-12-16
ES488665A0 ES488665A0 (es) 1980-12-16

Family

ID=8479833

Family Applications (1)

Application Number Title Priority Date Filing Date
ES488665A Granted ES488665A0 (es) 1980-02-15 1980-02-15 Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico

Country Status (3)

Country Link
BE (1) BE884722A (es)
ES (1) ES488665A0 (es)
FR (1) FR2476095A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692262B1 (fr) * 1992-06-10 1994-08-05 Adir Nouveaux nicotinates de diacylglycerols, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
PT1355644E (pt) 2001-01-26 2006-11-30 Schering Corp Utilização de compostos azetidinona substituídos para o tratamento de sitosterolemia
RS20100015A (sr) 2001-01-26 2010-12-31 Schering Corporation Kombinacija aktivatora receptora aktiviranog peroksizom- proliferatorom (ppar) fenofibrata sa inhibitorom apsorpcije sterola ezetimibom za vaskularne indikacije
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
EP1429756B1 (en) 2001-09-21 2006-11-22 Schering Corporation Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
JP2006508188A (ja) 2002-11-06 2006-03-09 シェーリング　コーポレイション 脱髄の処置のためのコレステロール吸収インヒビター
CN1756756A (zh) 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
CN1756755A (zh) 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
DE602004016123D1 (de) 2003-03-07 2008-10-09 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
TW200901959A (en) 2007-03-09 2009-01-16 Indigene Pharmaceuticals Inc Combination of metformin R-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications
TN2017000344A1 (en) 2015-02-06 2019-01-16 Intercept Pharmaceuticals Inc Pharmaceutical compositions for combination therapy
EA202193334A1 (ru) 2019-05-30 2022-03-14 Интерсепт Фармасьютикалз, Инк. Фармацевтические композиции, содержащие агонист fxr и фибрат, для применения при лечении холестатического заболевания печени

Also Published As

Publication number Publication date
FR2476095A1 (en) 1981-08-21
BE884722A (fr) 1980-12-01
FR2476095B1 (es) 1984-03-09
ES488665A0 (es) 1980-12-16

Similar Documents

Publication Publication Date Title
AU593317B2 (en) Pharmaceutical compositions
ES8101068A1 (es) Procedimiento para la preparacion de anilidas de acidos 4- amino-2-ureido-(o-tioureido)-pirimidin-5-carboxilicos
CA2069961A1 (en) Method and compositions for inhibition of disorders associated with oxidative damage
ES8201596A1 (es) Procedimiento de obtencion de mucopolisacaridos
EP0771191A4 (en) IMMUNOLOGICAL ACTIVITY OF RHAMNOLIPID
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
DE3365785D1 (en) Pharmaceutically active copolymers, process for their preparation and pharmaceutical compositions containing them
ATE1734T1 (de) Schmerzstillende tablette und verfahren zu deren herstellung.
DE68926115D1 (de) Verfahren zur behandlung von akne
ES8607916A1 (es) Un procedimiento para la preparacion de medicamentos influenciadores de la circulacion sanguinea, que contienen compuestos de bis (carboxamida)
JPS552601A (en) Anti-tumor agent for non-injection use
KR940013503A (ko) 동맥경화증의 예방 또는 치료용 약제학적 조성물
HUP9800964A2 (hu) O- és S-tartalmú 6 tagú benzo-kondenzált heterociklusos vegyületek, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények
ES466493A1 (es) Procedimiento de fabricacion de acidos a-aril-a -oxo-isovalericos.
ES8503649A1 (es) Procedimiento para preparar esteres de acidos benzosulfonicos substituidos
BE900607A (fr) Agents prophylactiques et medicaments anti-adhesifs contenant un derive de benzylamine ayant une action secretolytique.
IE810901L (en) Naphthotriazoles.
DE3369327D1 (en) Pharmaceutical compounds, preparation, use and intermediates therefor and their preparation
SE8402297L (sv) Pyridyl-n-oxider
WO1987003590A1 (fr) Medicament pour le traitement des maladies du foie
TNSN94110A1 (fr) Procede de preparation de compositions orales contenant des quinolones
JPS5498339A (en) Carcinostatic agent
SU686741A1 (ru) Способ гашени пены
JPS5742620A (en) Novel antiulcer agent
JPS5629600A (en) Novel 2-fluoro-n6,o2'-diacyl-adenosine-3',5'-cyclic phosphate, its preparation, and carcinostatic agent containing the same

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 19991217